Burt Wealth Advisors Eli Lilly & CO Transaction History

Burt Wealth Advisors

$399 Million
Q3 2024

A detailed history of Burt Wealth Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Burt Wealth Advisors holds 2,494 shares of LLY stock, worth $1.95 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

2,494

Previous 2,504 0.4%

Holding current value

$1.95 Million

Previous $2.27 Million 2.56%

% of portfolio

0.55%

Previous 0.6%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$772.14 - $960.02 $7,721 - $9,600	-10 Reduced 0.4%	2,494 $2.21 Million
Q2 2024 Jul 16, 2024	SELL	$724.87 - $909.04 $102,206 - $128,174	-141 Reduced 5.33%	2,504 $2.27 Million
Q1 2024 Apr 18, 2024	BUY	$592.2 - $792.28 $133,837 - $179,055	226 Added 9.34%	2,645 $2.06 Million
Q4 2023 Feb 01, 2024	SELL	$525.19 - $619.13 $18,381 - $21,669	-35 Reduced 1.43%	2,419 $1.41 Million
Q3 2023 Oct 11, 2023	SELL	$434.7 - $599.3 $81,288 - $112,069	-187 Reduced 7.08%	2,454 $1.32 Million
Q2 2023 Jul 18, 2023	SELL	$350.74 - $468.98 $4,559 - $6,096	-13 Reduced 0.49%	2,641 $1.24 Million
Q1 2023 Apr 13, 2023	BUY	$310.63 - $364.82 $931 - $1,094	3 Added 0.11%	2,654 $911,000
Q4 2022 Jan 17, 2023	SELL	$321.55 - $374.67 $10,611 - $12,364	-33 Reduced 1.23%	2,651 $970,000
Q3 2022 Oct 11, 2022	SELL	$296.48 - $337.87 $127,189 - $144,946	-429 Reduced 13.78%	2,684 $868,000
Q3 2021 Oct 06, 2021	SELL	$221.6 - $272.71 $76,895 - $94,630	-347 Reduced 10.03%	3,113 $719,000
Q2 2021 Jul 14, 2021	BUY	$180.55 - $233.54 $1,805 - $2,335	10 Added 0.29%	3,460 $794,000
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $3,913 - $5,178	-30 Reduced 0.86%	3,450 $582,000
Q2 2020 Aug 05, 2020	SELL	$136.42 - $164.18 $10,231 - $12,313	-75 Reduced 2.11%	3,480 $571,000
Q1 2020 Apr 29, 2020	SELL	$119.05 - $147.35 $8,928 - $11,051	-75 Reduced 2.07%	3,555 $493,000
Q4 2019 Jan 29, 2020	SELL	$106.92 - $132.43 $5,346 - $6,621	-50 Reduced 1.36%	3,630 $477,000
Q4 2018 Feb 08, 2019	SELL	$105.9 - $118.64 $5,295 - $5,932	-50 Reduced 1.34%	3,680 $426,000
Q3 2018 Oct 30, 2018	SELL	$85.86 - $107.31 $21,465 - $26,827	-250 Reduced 6.28%	3,730 $400,000
Q2 2018 Jul 27, 2018	SELL	$75.7 - $86.88 $11,355 - $13,032	-150 Reduced 3.63%	3,980 $340,000
Q4 2017 Jan 30, 2018	SELL	$81.94 - $87.89 $16,388 - $17,578	-200 Reduced 4.62%	4,130 $349,000
Q2 2017 Aug 07, 2017	BUY	N/A	4,330	4,330 $356,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burt Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Burt Wealth Advisors with notifications on news.

Account

Burt Wealth Advisors Eli Lilly & CO Transaction History